4 unknown. 4 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 4 |
| Phase 2 | 2 | Unknown 2 |
Follow Latent Infection: new trials by email Literature Review of Latent Infection trials Research Report on Latent Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cyclophosphamide in the Treatment of Refractory Proliferative Arachnoiditis in CNS Tuberculosis Cyclophosphamide injection - Tuberculosis, Tubercular Meningitis | Phase 2 / Phase 3 | Unknown | All India Institute of Medical Sciences | 40 | 2021-01-01 | 2020-12-30 |
| Efficacy of Nyaditum Resae(R) Against Active TB in Georgia Nyaditum resae(R), Placebo - Close Contacts of Active Tuberculosis | Phase 2 / Phase 3 | Unknown | Fundació Institut Germans Trias i Pujol | 3300 | 2017-03-10 | 2017-09-07 |
| Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan Rifapentine and Isoniazid for 3 months, Isoniazid for 9 months - Latent Tuberculosis Infection | Phase 3 | Unknown | National Taiwan University Hospital | 283 | 2014-08-01 | 2016-12-15 |
| Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI) 4-month rifampin vs. 9-month isoniazid - Latent Tuberculosis Infection | Phase 3 | Unknown | National Taiwan University Hospital | 300 | 2011-05-01 | 2011-07-20 |
Latent Tuberculosis (4) · Tuberculosis (3) · Arachnoiditis (1) · Tuberculosis, Meningeal (1)
Actinomycetales Infections (4) · Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Gram-Positive Bacterial Infections (4) · Infections (4) · Mycobacterium Infections (4) · Central Nervous System Bacterial Infections (1) · Central Nervous System Diseases (1) · Central Nervous System Infections (1) · Meningitis (1) · Meningitis, Bacterial (1) · Nervous System Diseases (1) · Neuroinflammatory Diseases (1) · Tuberculosis (1)
Isoniazid (2) · Cyclophosphamide (1) · rifapentine (1)
National Taiwan University Hospital (2) · All India Institute of Medical Sciences (1) · Fundació Institut Germans Trias i Pujol (1)
Taiwan (2) · Georgia (1)
Jann-Yuan Wang, MD. PhD. (1) · Jann-Yuan Wang, Ph.D. (1) · Pere-Joan Cardona, MD, PhD, Pr (1)